Human Papillomavirus Vaccination Status and Correlates Among Mid-Adult Women: Connecticut, USA, 2016-2019.

In 2019, the CDC expanded their recommendations for human papillomavirus (HPV) vaccination beyond age 26 years to include shared clinical decision-making (SCDM) among adults aged 27-45 years ("mid-adults"). The purpose of this study was to describe HPV vaccination status among mid-adult women before the implementation of SCDM for HPV vaccination. A cross-sectional survey was conducted during 2016-2019 in Connecticut, United States, and enrolled women born in 1981 or later (birth cohorts eligible for HPV vaccination).

State Laws Permitting Adolescent Consent to Human Papillomavirus Vaccination and Rates of Immunization.

This national cohort study examines National Immunization Survey–Teen to assess the association of adolescents’ ability to consent to human papillomavirus vaccination without parental involvement with vaccination rates.